- Cybersecurity
- Financial Institutions
- Energy
- Medical
- Agriculture
- Education
- Transport
FDA Embarks on Full AI Integration Following Pilot Program Success
The US Food and Drug Administration (FDA) has announced an immediate rollout of artificial intelligence tools across all of its centers, aiming for full operational integration by June 30. This decision follows the successful completion of a generative AI pilot designed to streamline scientific reviews and reduce the time spent...
Johnson & Johnson MedTech Partners with Qure.ai to Advance Lung Cancer Detection
In a pioneering move, Johnson & Johnson MedTech, a leader in surgical technologies, has entered a strategic partnership with Qure.ai, a company at the forefront of artificial intelligence (AI) in healthcare. This collaboration aims to transform the landscape of lung cancer detection in India, with a focus on early identification...
FDA Explores AI Integration to Speed Up Drug Approval Process
The Food and Drug Administration (FDA) has been exploring the possibility of using AI to speed up the drug approval process with recent negotiations with OpenAI being a breakthrough in the use of artificial intelligence to speed up reviews as reported by Wired. FDA Commissioner Marty Makary also spotlighted the...
Iambic Unveils Major Advances in AI-Driven Drug Discovery with Enchant v2
Iambic, a clinical-stage life science and technology company, has announced significant advancements in its multimodal transformer model, Enchant, designed for predicting clinical and preclinical endpoints in drug discovery and development. The new version, Enchant v2, marks a pivotal step forward in using large-scale transformers to tackle drug development challenges, offering...
